Recommendations for psoriasis treatment in Pediatrics

Authors

  • Paula Carolina Luna Hospital Alemán, Buenos Aires
  • María Eugenia Abad Servicio de Dermatología, Hospital Alemán, Buenos Aires
  • Margarita Larralde Servicio de Dermatología, Hospital Alemán, Buenos Aires
  • Paula Boggio Sección Dermatología Infantil del Departamento de Pediatría, Hospital Italiano de Buenos Aires
  • Bruno Ferrari Servicio de Dermatología, Hospital Ramos Mejía, Buenos Aires, Argentina
  • María Fernanda Maccario Servicio de Dermatología Pediátrica, Hospital de Niños V.J. Vilela, Rosario
  • Carla Castro Hospital Universitario Austral, Pilar, Argentina
  • Silvia Moreno Hospital Pediátrico Doctor Humberto Notti, Mendoza, Argentina
  • Débora Kaplan Consultorio privado, Buenos Aires
  • Cristina Echeverría Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

DOI:

https://doi.org/10.31053/1853.0605.v80.n4.42874

Keywords:

psoriasis, clinical practice guideline, Argentina, pediatrics, GRADE approach

Abstract

Introduction: in one third of patients with psoriasis, symptoms start during childhood and adolescence, with a strong emotional and psychosocial impact. Objective: to develop a guideline for the systemic treatment of psoriasis in pediatric patients by means of recommendations based on the best available evidence. Materials and methods: Sources: articles indexed in PubMed, Epistemonikos, Google Scholar, Cochrane Library and Scielo, published between January 2010 and May 2022, in English, Spanish and Portuguese. Study selection: evidence-based clinical practice guidelines, systematic reviews, meta-analyses, randomized controlled studies, observational studies (case-control, cohort studies, real-life registries) and evaluations of biosimilar drugs in patients up to and including 17 years of age were considered. The keywords "psoriasis" and "treatment" were used in all three languages. Data extraction: the literature was evaluated using Grading of Recommendations Assessment, Development and Evaluation (GRADE) recommendations. Data synthesis: evidence tables were developed and analyzed by the expert committee. The questions for the development of recommendations were based on the PICO system (population, intervention, comparison, outcome). Results: A total of 8 recommendations and 7 points of good practice were developed. The direction and strength of the recommendations were expressed according to the GRADE system. Conclusions: the final decision on a specific therapy should be based on the best opinion of the treating physician, the individual characteristics, and the values and preferences of the patients and their caregivers.

Downloads

Download data is not yet available.

Author Biographies

María Eugenia Abad, Servicio de Dermatología, Hospital Alemán, Buenos Aires

Médica dermatóloga y dermatopediatra, subdirectora de la Carrera de Especialista en Dermatología Pediátrica de la Universidad de Buenos Aires

Margarita Larralde, Servicio de Dermatología, Hospital Alemán, Buenos Aires

Médica dermatóloga y dermatopediatra, Profesora Titular de Dermatología de la Universidad de Buenos Aires

Paula Boggio, Sección Dermatología Infantil del Departamento de Pediatría, Hospital Italiano de Buenos Aires

Médica dermatóloga y dermatopediatra, asociada de la Sección Dermatología Infantil, Departamento de Pediatría, Hospital Italiano de Buenos Aires

Bruno Ferrari, Servicio de Dermatología, Hospital Ramos Mejía, Buenos Aires, Argentina

Médico dermatólogo graduado en la Universidad Nacional de Córdoba y especializado en la Universidad de Buenos Aires

María Fernanda Maccario, Servicio de Dermatología Pediátrica, Hospital de Niños V.J. Vilela, Rosario

Médica pediatra y dermatóloga, directora de la Sociedad de Dermatología Pediátrica para Latinoamérica

Carla Castro, Hospital Universitario Austral, Pilar, Argentina

Médica pediatra y dermatóloga, docente adjunta profesional de la Cátedra de Dermatología de la Facultad de Ciencias Biomédicas de la Universidad Austral y docente asociada de la Cátedra de Dermatología de la Facultad de Medicina de la Universidad Católica de Cuyo (sede San Luis)

Silvia Moreno, Hospital Pediátrico Doctor Humberto Notti, Mendoza, Argentina

Médica dermatopediatra, Profesora titular de la Catedra de Dermatología de la Universidad de Mendoza

Débora Kaplan, Consultorio privado, Buenos Aires

Médica dermatóloga, presidenta de SOARPSO

Cristina Echeverría, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

Médica dermatóloga, ex presidenta de SOARPSO

References

Gisondi P, Fostini AC, Fossà I, Girolomoni G, Targher G. Psoriasis and the metabolic syndrome. Clin Dermatol. 2018 Jan-Feb;36(1):21-28. doi: 10.1016/j.clindermatol.2017.09.005.

Paller AS, Singh R, Cloutier M, Gauthier-Loiselle M, Emond B, Guérin A, Ganguli A. Prevalence of Psoriasis in Children and Adolescents in the United States: A Claims-Based Analysis. J Drugs Dermatol. 2018 Feb 1;17(2):187-194.

Murzina E. Pediatric Psoriasis: Clinical Features and Course. Open Acc J Bio Sci. 2020;2(1):207–9. doi: 10.38125/OAJBS.000147.

Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Schünemann HJ, Edejer T, Varonen H, Vist GE, Williams JW Jr, Zaza S; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004 Jun 19;328(7454):1490. doi: 10.1136/bmj.328.7454.1490.

American Academy of Family Physicians. Clinical Practice Guideline Manual. [Internet]. Disponible en: http://bit.ly/3rgZOOT

Amatore F, Villani AP, Tauber M, Viguier M, Guillot B; Psoriasis Research Group of the French Society of Dermatology (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie). French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):464-483. doi: 10.1111/jdv.15340.

Mahé E. Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives. Psoriasis (Auckl). 2020 Nov 27;10:45-56. doi: 10.2147/PTT.S222729.

Menter A, Cordoro KM, Davis DMR, Kroshinsky D, Paller AS, Armstrong AW, Connor C, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Elmets CA. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020 Jan;82(1):161-201. doi: 10.1016/j.jaad.2019.08.049. Erratum in: J Am Acad Dermatol. 2020 Mar;82(3):574.

Devaux S, Castela A, Archier E, Gallini A, Joly P, Misery L, Aractingi S, Aubin F, Bachelez H, Cribier B, Jullien D, Le Maître M, Richard MA, Ortonne JP, Paul C. Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review. J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:52-60. doi: 10.1111/j.1468-3083.2012.04524.x.

Olsen EA. Efficacy and safety of fluticasone propionate 0.005% ointment in the treatment of psoriasis. Cutis. 1996 Feb;57(2 Suppl):57–61.

Pauporte M, Maibach H, Lowe N, Pugliese M, Friedman DJ, Mendelsohn H, Cargill I, Ramirez R. Fluocinolone acetonide topical oil for scalp psoriasis. J Dermatolog Treat. 2004 Dec;15(6):360-4. doi: 10.1080/09546630410023566.

Stein LF, Sherr A, Solodkina G, Gottlieb AB, Chaudhari U. Betamethasone valerate foam for treatment of nonscalp psoriasis. J Cutan Med Surg. 2001 Jul-Aug;5(4):303-7. doi: 10.1007/s10227-001-0006-0.

Castela E, Archier E, Devaux S, Gallini A, Aractingi S, Cribier B, Jullien D, Aubin F, Bachelez H, Joly P, Le Maître M, Misery L, Richard MA, Paul C, Ortonne JP. Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities. J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:36-46. doi: 10.1111/j.1468-3083.2012.04522.x.

Thomas J, Parimalam K. Treating pediatric plaque psoriasis: challenges and solutions. Pediatric Health Med Ther. 2016 Apr 21;7:25-38. doi: 10.2147/PHMT.S75834.

15.Boztepe G, Karaduman A, Sahin S, Hayran M, Kölemen F. The effect of maintenance narrow-band ultraviolet B therapy on the duration of remission for psoriasis: a prospective randomized clinical trial. Int J Dermatol. 2006 Mar;45(3):245-50. doi: 10.1111/j.1365-4632.2004.02398.x.

Ersoy-Evans S, Altaykan A, Sahin S, Kölemen F. Phototherapy in childhood. Pediatr Dermatol. 2008 Nov-Dec;25(6):599-605. doi: 10.1111/j.1525-1470.2008.00773.x.

Sociedad Argentina de Psoriasis. Guías argentinas de tratamiento sistémico de la psoriasis moderada a severa en pacientes adultos, 2020 PSOARPSO. [Internet]. Disponible en: http://www.soarpso.org/recursos/archivos/AG_psoriasis_2020_espanol.pdf.

Goenaga-Vázquez Y, Lauck KC, Hebert AA. Therapeutic challenges in managing pediatric psoriasis. Int J Womens Dermatol. 2020 Oct 10;7(3):314-318. doi: 10.1016/j.ijwd.2020.09.012.

19.Mrowietz U, Domm S. Systemic steroids in the treatment of psoriasis: what is fact, what is fiction? J Eur Acad Dermatol Venereol. 2013 Aug;27(8):1022-5. doi: 10.1111/j.1468-3083.2012.04656.x.

Schwarz CW, Loft N, Andersen V, Juul L, Zachariae C, Skov L. Are Systemic Corticosteroids Causing Psoriasis Flare-Ups? Questionnaire for Danish Dermatologists, Gastroenterologists and Rheumatologists. Dermatology. 2021;237(4):588-594. doi: 10.1159/000510712.

Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A, Griffiths C, Hönigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009 Oct;23 Suppl 2:1-70. doi: 10.1111/j.1468-3083.2009.03389.x.

van Geel MJ, Oostveen AM, Hoppenreijs EP, Hendriks JC, van de Kerkhof PC, de Jong EM, Seyger MM. Methotrexate in pediatric plaque-type psoriasis: Long-term daily clinical practice results from the Child-CAPTURE registry. J Dermatolog Treat. 2015 Oct;26(5):406-12. doi: 10.3109/09546634.2014.996515.

Chen P, Li C, Xue R, Chen H, Tian X, Zeng K, Zhang X, Liang J. Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review. J Dermatolog Treat. 2018 Jun;29(4):353-363. doi: 10.1080/09546634.2017.1395798.

Popadic S, Nikolic M. Pustular psoriasis in childhood and adolescence: a 20-year single-center experience. Pediatr Dermatol. 2014 Sep-Oct;31(5):575-9. doi: 10.1111/pde.12296.

Sun HY, Phan K, Paller AS, Sebaratnam DF. Biologics for pediatric psoriasis: A systematic review and meta-analysis. Pediatr Dermatol. 2022 Jan;39(1):42-48. doi: 10.1111/pde.14870.

Olejniczak-Staruch I, Ciążyńska M, Sobolewska-Sztychny D, Narbutt J, Skibińska M, Lesiak A. Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis. Int J Mol Sci. 2021 Apr 13;22(8):3998. doi: 10.3390/ijms22083998.

Published

2023-12-26

How to Cite

1.
Luna PC, Abad ME, Larralde M, Boggio P, Ferrari B, Maccario MF, Castro C, Moreno S, Kaplan D, Echeverría C. Recommendations for psoriasis treatment in Pediatrics. Rev Fac Cien Med Univ Nac Cordoba [Internet]. 2023 Dec. 26 [cited 2024 May 14];80(4):523-37. Available from: https://revistas.unc.edu.ar/index.php/med/article/view/42874